Literature DB >> 1969411

Selective modulation of the endocytic uptake of ricin and fluid phase markers without alteration in transferrin endocytosis.

K Sandvig1, B van Deurs.   

Abstract

Cytochalasin D was found to reduce the endocytosis of ricin and the fluid phase markers [14C]sucrose and Lucifer Yellow in Vero cells without reducing the uptake of transferrin. The number of coated pits at the plasma membrane was not affected by the treatment. Cytochalasin D also reduced the endocytosis of ricin in cells where uptake of transferrin from coated pits was blocked by low cytosolic pH. Colchicine had a similar effect as cytochalasin D. Both drugs inhibited the exocytosis of ricin from the cells, and they reduced the rate by which ricin intoxicated the cells. Cytochalasin D had essentially no effect on the ability of the cells to bind transferrin, whereas colchicine reduced the binding to some extent. Epidermal growth factor (EGF) and 12-O-tetradecanoylphorbol-13-acetate (TPA) increased the endocytic uptake of ricin in A431 cells both under normal culture conditions and when the coated pit/coated vesicle pathway was blocked by acidification of the cytosol. In contrast, EGF and TPA had no stimulatory effect on the uptake of transferrin at normal cytoplasmic pH, and they did not abolish the ability of low cytoplasmic pH to inhibit endocytic uptake of transferrin. The results indicate that cytochalasin D and colchicine selectively inhibit endocytic uptake from non-clathrin-coated areas of the cell membrane whereas EGF and TPA stimulate it. The data support the view that there are different endocytic mechanisms, and they indicate that at least in some cell types the non-clathrin-coated endocytosis can be modulated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969411

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Regulation of macropinocytosis by p21-activated kinase-1.

Authors:  S Dharmawardhane; A Schürmann; M A Sells; J Chernoff; S L Schmid; G M Bokoch
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

Review 2.  Hijacking the endocytic machinery by microbial pathogens.

Authors:  Ann En-Ju Lin; Julian Andrew Guttman
Journal:  Protoplasma       Date:  2010-06-25       Impact factor: 3.356

3.  Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.

Authors:  G W Small; J C Strum; L W Daniel
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

Review 4.  Molecular mechanisms of clathrin-independent endocytosis.

Authors:  Carsten G Hansen; Benjamin J Nichols
Journal:  J Cell Sci       Date:  2009-06-01       Impact factor: 5.285

Review 5.  Building endocytic pits without clathrin.

Authors:  Ludger Johannes; Robert G Parton; Patricia Bassereau; Satyajit Mayor
Journal:  Nat Rev Mol Cell Biol       Date:  2015-04-10       Impact factor: 94.444

6.  Evidence from lateral mobility studies for dynamic interactions of a mutant influenza hemagglutinin with coated pits.

Authors:  E Fire; D E Zwart; M G Roth; Y I Henis
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

Review 7.  Physiological functions of endosomal proteolysis.

Authors:  T Berg; T Gjøen; O Bakke
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

8.  Pertussis toxin-catalyzed ADP-ribosylation of Gi-2 and Gi-3 in CHO cells is modulated by inhibitors of intracellular trafficking.

Authors:  Y Xu; J T Barbieri
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

9.  Brefeldin A inhibits the endocytosis of plasma-membrane-associated heparan sulphate proteoglycans of cultured rat ovarian granulosa cells.

Authors:  L Uhlin-Hansen; M Yanagishita
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

10.  Cytoskeleton-dependent endocytosis is required for apical type 1 angiotensin II receptor-mediated phospholipase C activation in cultured rat proximal tubule cells.

Authors:  J R Schelling; A S Hanson; R Marzec; S L Linas
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.